



Newcastle Disease, Infectious Bronchitis, Egg Drop Syndrome and Avian Influenza (H9 Subtype) Vaccine,Inactivated
- China’s top vaccine factory
- Support Inspection Factory
- OEM/ODM, Wholesale
- Certificate: ISO, CQC, GMP, FDA
- On-Time Delivery
- Free Sample
- 7/24 Hours Free Customer Service
Generic name of product
Newcastle Disease, Infectious Bronchitis, Egg Drop Syndrome and Avian Influenza (H9 Subtype) Vaccine,Inactivated
Main Ingredients and Content
The vaccine contains inactivated Newcastle disease virus (sub-genotype VII), with a pre-inactivation titer of ≥ 3 × 109.0EID50/0.1 mL; Infectious Bronchitis virus strain QX, with a pre-inactivation titer of ≥ 1 × 107.5EID50/0.1 mL; and inactivated Avian Influenza virus (H9N2 subtype, clades 4.1.a and 4.1.b), each with a pre-inactivation titer of ≥ 3 × 109.0EID50/0.1 mL. The inactivated Egg Drop Syndrome virus (strain HE02) has a pre-inactivation titer of ≥ 4 × 107.0EID50/mL.
Character
Milky white uniform emulsion
Function and Purpose
For the prevention of Newcastle Disease, Infectious Bronchitis, Egg Drop Syndrome and H9 subtype Avian Influenza The duration of immunity is 4 months.
Usage and Dosage
Subcutaneous injection in the next region. For layers 2~3 weeks before production and breeders, 0.5 ml/dose.
Adverse Reactions
Generally no adverse reactions.
Precautions
- 1.Used only for healthy chicks.
- 2.Shake well and allow the vaccine to room temperature before use.
- 3.This product should be used up within 24 hours after opening.
- 4.This product should not be frozen.
- 5.This product cannot be used if there is any foreign matter or demulsification
- 6.Hazardless processing should be conducted out for used vaccine bottles, instruments, and remaining vaccines.
Storage and Period of Validity
2-8℃ preservation, valid for 24 months.
Specifications
(1)250mL/bottle, 40bottles/carton (2)500mL/bottle, 20bottles/carton
Only under the guidance of the veterinary use
1.One injection provides four protections – an innovative breakthrough in China that improves disease prevention efficiency, enhances effectiveness, and reduces farm workload.
2.Serotype-matched, highly concentrated viral subunit antigens formulated in scientifically optimized proportions.
3.Adjuvant formulation ensures zero stress and delivers high-efficiency protection using compound vegetable oil technology.
4.The adoption of a customized H9 Avian Influenza strain model enables meeting the needs of different countries for prevalent strains.
5.Classic antigen combination, essential and highly cost-effective for layer and breeding.